USV is a 62 year young Indian healthcare company with pharmaceutical manufacturing & research and marketing capabilities for Pharma & Consumer business. The company started as a subsidiary of Revlon and now operates as an independent entity in domestic and international markets. Built on deeply rooted Credo values, the company is leading in therapeutic segments like Cardio and Diabetology in India. It is also significant in Vitamins, Minerals, Nutrients, Dermatology, Gastroenterology and CNS. USV’s International business consists of a portfolio of small molecule APIs (31 of which are commercially available) and finished dosages exported to 65+ countries. It has 7 manufacturing plants across India (4 for Formulation, 2 for APIs & 1 for Biological Drugs), a Corporate office and a Research & Development Center in Mumbai with the help of 6800+ human capital. The facilities are accredited by global regulators such as USFDA, EMA, MHRA & others and are cGMP compliant. USV’s promise of being a reliable health partner to its customers and stakeholders is reflected in its leadership position in the Oral Anti-Diabetic market - ranked #1 by Rx and Value and in the Cardiovascular diseases segment - ranked #1 by Rx and #4 by Value. The company invests 3% of its revenue in R&D and has received a grant for 12 patents. USV’s Consumer Business: Sebamed is a leading Baby and Personal care brand. Other segments include Beauty, Food, and nutrition. It ranks #3 in Indian Baby care and is growing exponentially. USV lives by the culture of excellence through quality products, therapy leadership, a robust supply chain and sustainable practices & giving back to society. USV Credos: Customer Orientation, Collaboration, Commitment, Challenge, Communication, and Cheerfulness are guiding forces in how it operates.
